Hrabe, J. E., O’Leary, B. R., Fath, M. A., Rodman, S. N., Button, A. M., Domann, F. E., . . . Mezhir, J. J. (2015). Disruption of thioredoxin metabolism enhances the toxicity of transforming growth factor β-activated kinase 1 (TAK1) inhibition in KRAS-mutated colon cancer cells. Redox Biol.

Hrabe, Jennifer E., Brianne R. O’Leary, Melissa A. Fath, Samuel N. Rodman, Anna M. Button, Frederick E. Domann, Douglas R. Spitz, and James J. Mezhir. "Disruption of Thioredoxin Metabolism Enhances the Toxicity of Transforming Growth Factor β-activated Kinase 1 (TAK1) Inhibition in KRAS-mutated Colon Cancer Cells." Redox Biol 2015.

Hrabe, Jennifer E., et al. "Disruption of Thioredoxin Metabolism Enhances the Toxicity of Transforming Growth Factor β-activated Kinase 1 (TAK1) Inhibition in KRAS-mutated Colon Cancer Cells." Redox Biol 2015.